Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Terumo Corp    4543   JP3546800008

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Terumo : Expands Production in Asia New Factory Established and Existing Facilities Expanded in Vietnam and the Philippines

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/10/2012 | 08:13am CET
May 10, 2012

Terumo Corporation (TOKYO:4543) announced today that it will expand its production facilities in Asia to meet anticipated sales increases in the medium to long term, based on its corporate growth strategy. Terumo Corporation will establish a new factory in Vietnam, its second in the country, as well as expand the production scale of existing factories in Vietnam and the Philippines. The total amount invested will be 15 billion yen.

The new factory in Vietnam will produce blood management products such as blood bags to meet growing global demand, especially in emerging countries.
In cooperation with Ashitaka factory (Shizuoka prefecture) and the new Yamaguchi factory in Japan (operation to be started in 2015), the existing factory in Vietnam will expand the production scale of interventional systems products, sales of which have been growing at a double-digit pace. The company will also establish a new production building at the existing factory in the Philippines to cope with needed production increases of syringes and needles.
To improve its global competitiveness, Terumo Corporation is seeking to enhance the production capacity across all of its three business areas: Cardiac & Vascular, General Hospital, and Blood Management.

Terumo Corporation's global production system

Terumo Corporation is accelerating its growth globally, and plans to increase the percent of production done outside Japan in line with the growth in the share of net sales outside Japan, which already account for over half of the total. Accordingly, the company has positioned factories in Asia as its global production center and is already producing a broad range of products in China, the Philippines, and Vietnam.
On another front, certain highly advanced and precise production technologies are difficult to transfer outside of Japan. The company has designated factories in Japan as mother production factories that develop and refine core manufacturing technologies to underpin product improvement.
Terumo Corporation will continue to enhance its global production system in factories in Asia and Japan to meet growing global demand while increasing cost competitiveness.

Factories Overview 1. Vietnam: a new factory to be established

In April 2012, Terumo BCT was established through the integration of CaridianBCT and Terumo Transfusion, following Terumo Corporation's acquisition of CaridianBCT in April 2011. The company will establish a new factory in Vietnam to produce blood management products to meet growing global demand, especially in emerging countries. The factory will be its sixth production facilities of blood management products, following ones in Japan, U.S., UK

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on TERUMO CORP
03/23 GLOBAL CARDIOPULMONARY AUTOTRANSFUSI : Wansong Health Sources, Terumo, LivaNova,..
03/17 Special Purpose Needles Market 2017 - Cook Medical, MEDTRONIC, Smith's Medica..
03/17 GLOBAL EXTRACORPOREAL MEMBRANE OXYGE : Medtronic, Maquet Holding, Sorin Group, T..
03/16 TERUMO : MicroVention® And Terumo Corporation Announce Data From Multicenter GRE..
03/16 MEDTRONIC : Global Heart Lung Machine Market- Medtronic, Sorin, Terumo, Braile B..
03/15 MEDTRONIC : Global Neuroendovascular Coil Market 2017- MicroVention, Penumbra, S..
03/10 GLOBAL RADIAL COMPRESSION DEVICES MA : Terumo Corporation, Merit Medical, Abbott..
03/09 Global Neurovascular Devices Market-Terumo, Medtronic, Penumbra, Abbott Vascu..
03/07 TERUMO : Vanguard Software Slashes Forecast Prep and Reporting Time, Boosts Fore..
03/06 TERUMO : Vanguard Software Slashes Forecast Prep and Reporting Time, Boosts Fore..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
03/22DJMEDTRONIC : Files 8K - Other Events
03/17DJMEDTRONIC : Less-Invasive Treatment Yielded Similar Outcome as Open-Heart Surger..
03/11DJLUXOTTICA : Smart Glasses Get a Fresh Look -- WSJ
03/09DJLUXOTTICA : Eyewear Makers Take a Fresh Look at Smart Glasses
03/09DJLUXOTTICA : Eyewear Makers Rethink Smart Glasses
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
2016 HAEMONETICS : Investor Patience Is Wearing Thin
2016 Terumo Corp. ADR 2017 Q2 - Results - Earnings Call Slides
2016 Abbott's Vascular Products Sale Likely Done To Address Regulatory Concerns
2016 Abbott's Vascular Tech Is Big In Japan
2016 Abbott and St. Jude to jettison vascular closure products to Terumo for $1.1B
Advertisement
Financials ( JPY)
Sales 2017 509 534 M
EBIT 2017 -
Net income 2017 49 065 M
Debt 2017 108 569 M
Yield 2017 1,03%
P/E ratio 2017 29,12
P/E ratio 2018 25,25
EV / Sales 2017 3,14x
EV / Sales 2018 2,84x
Capitalization 1 490 560 M
More Financials
Chart TERUMO CORP
Duration : Period :
Terumo Corp Technical Analysis Chart | 4543 | JP3546800008 | 4-Traders
Full-screen chart
Technical analysis trends TERUMO CORP
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 4 593  JPY
Spread / Average Target 17%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Yutaro Shintaku President & Representative Director
Ryo Nishihata Chief Accounting & Financial Officer, IR Contact
Hiroaki Kasukawa CTO, Executive Officer, GM-Research & Development
Katsuya Takeuchi Executive Officer & Chief Information Officer
Takayoshi Mimura Director & Senior Managing Executive Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
TERUMO CORP-9.25%13 384
MEDTRONIC PLC13.72%110 880
BAXTER INTERNATIONAL I..17.32%28 193
ZIMMER BIOMET HOLDINGS..16.92%24 265
HOYA CORPORATION9.63%18 882
C R BARD INC11.24%18 072
More Results